Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RIC biologics is a European center of excellence providing comprehensive analytical solutions for pharmaceutical and biotechnology companies. The company specializes in supporting the development of biological products and chemical entities through advanced analytics, including characterization, quantification, stability testing, comparability studies, formulation support, dossier preparation for regulatory submissions, and more. Their expertise covers a wide range of modalities such as monoclonal antibodies (including biobetters and biosimilars), ADCs, bispecifics/multispecifics, fusion proteins, enzymes/peptides/oligonucleotides/DNA/RNA/small molecules/cell-based products/vaccines[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RICBT.